COMT-inhibition: An important option in treatment of Parkinson's disease

被引：0

作者：

Reichmann, H ^{[1
]}

机构：

[1] Tech Univ Dresden, Neurol Klin & Poliklin, D-01307 Dresden, Germany

来源：

AKTUELLE NEUROLOGIE | 2005年 / 32卷

关键词：

D O I：

10.1055/s-2005-866979

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S297 / S298

页数：2

共 50 条

[1] The Impact of COMT-inhibition on Gastrointestinal Levodopa Absorption in Patients with Parkinson's Disease
Mueller, Thomas
[J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 155 - 168
[2] COMT inhibition in the treatment of Parkinson's disease
Ruottinen, HM
Rinne, UK
[J]. JOURNAL OF NEUROLOGY, 1998, 245 (Suppl 3) : P25 - P34
[3] COMT inhibition in the treatment of Parkinson’s disease
H. M. Ruottinen
U. K. Rinne
[J]. Journal of Neurology, 1998, 245 : P25 - P34
[4] COMT-inhibition increases serum levels of dihydroxyphenylacetic acid (DOPAC) in patients with advanced Parkinson's disease
Oechsner, M
Buhmann, C
Strauss, J
Stuerenburg, HJ
[J]. JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (01) : 69 - 75
[5] Position of COMT inhibition in the treatment of Parkinson's disease
Gordin, AR
Kaakkola, T
Teräväinen, H
[J]. PARKINSON'S DISEASE, 2003, 91 : 237 - 250
[6] The role of COMT inhibition in the treatment of Parkinson's disease
Poewe, W
[J]. NEUROLOGY, 2004, 62 (01) : S31 - S38
[7] COMT-inhibition increases serum levels of dihydroxyphenylacetic acid (DOPAC) in patients with advanced Parkinson's disease
M. Oechsner
C. Buhmann
J. Strauss
H. J. Stuerenburg
[J]. Journal of Neural Transmission, 2002, 109 : 69 - 75
[8] COMT-inhibition for treatment of wearing-off
Reichmann, H
[J]. AKTUELLE NEUROLOGIE, 2005, 32 : S317 - S317
[9] COMT inhibition in Parkinson's disease
Olanow, CW
Obeso, JA
[J]. NEUROLOGY, 2000, 55 (11) : S1 - S1
[10] Relevance of MAO and COMT inhibition to the treatment of Parkinson's disease
Jenner, P
[J]. FOCUS ON DEPRESSION AND ANXIETY, 1996, 7 (04): : 83 - 83

← 1 2 3 4 5 →